-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Outperform on Belite Bio, Raises Price Target to $234

Benzinga·09/09/2026 14:31:07
Listen to the news
Mizuho analyst Graig Suvannavejh maintains Belite Bio (NASDAQ:BLTE) with a Outperform and raises the price target from $220 to $234.